Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
- 1Department of Bioengineering, Institute of Bioorganic Chemistry (RAS), Moscow, Russia
- 2Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia
- 3Department of X-Ray and Synchrotron Research, A.V. Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics” of Russian Academy of Sciences, Moscow, Russia
by Artykov, A. A., Yagolovich, A. V., Dolgikh, D. A., Kirpichnikov, M. P., Trushina, D. B., and Gasparian M. E. (2021). Front. Cell Dev. Biol. 9:733688. doi: 10.3389/fcell.2021.733688
In the original article there was an error in the Funding statement. The statement was missing a link for the funder “Russian Science Foundation.” The corrected Funding statement appears below.
This work was supported by the Russian Science Foundation (Grant No. 21-14-00224, https://rscf.ru/project/21-14-00224/; AA, MG, and DD production of recombinant TRAIL and DR5-B, TRAIL-mediated receptors traffic), by budgetary funding, AY, MK for western blot and ELISA analysis and of Lomonosov Moscow State University (Moscow, Russia). The confocal laser scanning microscopy study DT was performed using the equipment of the Shared Research Center FSRC “Crystallography and Photonics” RAS and supported by the Ministry of Science and Higher Education of the Russian Federation within the State assignment FSRC “Crystallography and Photonics” RAS.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: DR5, DR4, receptor endocytosis, receptor recycling, membrane traffic, brefeldin A
Citation: Artykov AA, Yagolovich AV, Dolgikh DA, Kirpichnikov MP, Trushina DB and Gasparian ME (2022) Corrigendum: Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL. Front. Cell Dev. Biol. 9:820069. doi: 10.3389/fcell.2021.820069
Received: 22 November 2021; Accepted: 24 November 2021;
Published: 14 February 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Artykov, Yagolovich, Dolgikh, Kirpichnikov, Trushina and Gasparian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Marine E. Gasparian, bWFyaW5lX2dhc3BhcmlhbkB5YWhvby5jb20=